Sorrento Therape Financials
| SRNE Stock | USD 0.0006 0 84.21% |
With this module, you can analyze Sorrento financials for your investing period. You should be able to track the changes in Sorrento Therape individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Sorrento |
The data published in Sorrento Therape's official financial statements typically reflect Sorrento Therape's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Sorrento Therape's quantitative information. For example, before you start analyzing numbers published by Sorrento accountants, it's essential to understand Sorrento Therape's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
Please note, the presentation of Sorrento Therape's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sorrento Therape's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sorrento Therape's management manipulating its earnings.
Sorrento Therape Stock Summary
Sorrento Therape competes with Allient, Alto Neuroscience,, FARO Technologies, Skyworks Solutions, and Asure Software. Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. The company was founded in 2006 and is based in San Diego, California. Sorrento Therpt operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 799 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQB Exchange |
| ISIN | US83587F2020 |
| Business Address | 4955 Directors Place, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.sorrentotherapeutics.com |
| Phone | 858 203 4100 |
| Currency | USD - US Dollar |
Sorrento Therape Key Financial Ratios
There are many critical financial ratios that Sorrento Therape's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Sorrento Therape reports annually and quarterly.| Return On Equity | -3.79 | |||
| Return On Asset | -0.41 | |||
| Target Price | 13.0 | |||
| Number Of Employees | 949 | |||
| Beta | 1.84 |
Sorrento Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sorrento Therape's current stock value. Our valuation model uses many indicators to compare Sorrento Therape value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sorrento Therape competition to find correlations between indicators driving Sorrento Therape's intrinsic value. More Info.Sorrento Therape is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sorrento Therape's earnings, one of the primary drivers of an investment's value.Sorrento Therape Systematic Risk
Sorrento Therape's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sorrento Therape volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Beta measures systematic risk based on how returns on Sorrento Therape correlated with the market. If Beta is less than 0 Sorrento Therape generally moves in the opposite direction as compared to the market. If Sorrento Therape Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sorrento Therape is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sorrento Therape is generally in the same direction as the market. If Beta > 1 Sorrento Therape moves generally in the same direction as, but more than the movement of the benchmark.
Sorrento Therape February 17, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sorrento Therape help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sorrento Therape. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sorrento Therape based on widely used predictive technical indicators. In general, we focus on analyzing Sorrento OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sorrento Therape's daily price indicators and compare them against related drivers.
| Downside Deviation | 38.26 | |||
| Information Ratio | 0.159 | |||
| Maximum Drawdown | 1884.21 | |||
| Value At Risk | (60.00) | |||
| Potential Upside | 66.67 |
Complementary Tools for Sorrento OTC Stock analysis
When running Sorrento Therape's price analysis, check to measure Sorrento Therape's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sorrento Therape is operating at the current time. Most of Sorrento Therape's value examination focuses on studying past and present price action to predict the probability of Sorrento Therape's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sorrento Therape's price. Additionally, you may evaluate how the addition of Sorrento Therape to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |